ArticleInfection and drug resistance2024
Five Years' Experience with Respiratory Syncytial Virus Among Hospitalized Patients: A Retrospective Study from Jazan, Saudi Arabia.
Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: RSV is a common seasonal cause of respiratory infections in children and potentially adults and is considered a major cause of mortality and morbidity. While several studies on RSV have been conducted in Saudi Arabia, none have specifically focused on the southwestern region, where distinct climatic and demographic factors may influence RSV pattern. The current study aims to describe five years of experience with RSV cases among hospitalized patients and factors associated with intensive care admission from a tertiary hospital. Materials and Methods: The study adopts a retrospective observational design, focusing on suspected respiratory infection cases confirmed by rapid RSV antigen tests from 2015 to 2020. Data including age, sex, comorbidities, and outcomes were collected from a tertiary hospital's medical records and microbiology laboratory files. Data were analyzed using a Results: Among 195 participants, primarily pediatric, monthly, and yearly admissions varied. Monthly variations revealed a U-shaped pattern with most cases reported during January, with a decline in 2020. Oxygen support was required for 40% of cases, and comorbidities were observed in 49.23%. Associations between ICU admission and factors like age, gestational age, ventilation, comorbidities, and length of stay were significant. Conclusion: RSV infection is one of the important causes of morbidity and intensive care admission among infants and young children in Saudi Arabia. As reported by others, the seasonality of RSV is evident. Despite higher prevalence in a younger population, physicians should consider RSV in adults and older patients. Further national studies are required for a better estimation of the RSV burden on the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.